UB LAUNCHES STUDY

The University of Botswana this week launched a study titled ‘Thibang diphatlha,’ which involves testing adaptive strategies to close the gap from cervical cancer diagnosis to treatment in Botswana. Cervical cancer is one of the most common female cancers globally, with approximately 90 percent of cases and deaths occurring in low-and-middle-incomecountries particularly those with high rates of HIV like Botswana. Collaborating with the Ministry of Health, University of Pennsylvania and Botswana-Upenn partnership, UB investigators will test the effectiveness of adaptive strategies on timely treatment adoption using a hybrid (type iii) and pragmatic sequential multiple assignment randomised trial (smart) design, complemented by an evaluation using mixed-methods.